Research on Pfizer Inc. and Bristol-Myers Squibb Co. - Major Drug Manufacturers Look to Grow Revenues in Wake of Patent Expiries
(firmenpresse) - JOHANNESBURG, SOUTH AFRICA -- (Marketwire) -- 05/29/12 -- offers investors comprehensive research on the Drug Manufacturers - Major industry and has completed analytical research on (NYSE: PFE) and (NYSE: BMY). Register with us today at to have free access to these researches.
For major drug manufacturers such as Pfizer Inc. and Bristol-Myers Squibb Co., patent expiries have certainly created challenges over the last little while. Pfizer reported a decline in 1st quarter U.S. revenue recently, mostly due to its loss of exclusivity for Lipitor. Similarly, the patent expiry of Plavix will certainly impact Bristol-Myers Squibb moving forward. Investors can register for free to access the research reports on and at or .
is an online platform where investors doing their due-diligence on the Drug Manufacturers - Major industry can have easy and free access to our analyst research and opinions on Pfizer Inc. and Bristol-Myers Squibb Co.; investors and shareholders of these companies can simply register for a complimentary membership at .
While patent expiries have taken their toll, companies have been actively trying to grow revenues by other means. Bristol-Myers Squibb is a good example of this, having recently won FDA approval for its biologics manufacturing facility, located in Devens, Massachusetts. The facility will produce ORENCIA®, and will put the company in a strong position to produce other biologic medicines moving forward. Visit to see how companies in this industry have grown over the past years and how they are expected to perform in the future.
In an attempt to bolster Lipitor sales, Pfizer, in partnership with Eatingwell Media Group, has launched a mobile app called Pfizer's Lipitor For You "Recipes 2 Go." The app focuses on heart health. Register now at to have free access to our reports on the Drug Manufacturers - Major industry.
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.05.2012 - 12:15 Uhr
Sprache: Deutsch
News-ID 150659
Anzahl Zeichen: 0
contact information:
Town:
JOHANNESBURG, SOUTH AFRICA
Kategorie:
Investment Services & Trading
Diese Pressemitteilung wurde bisher 197 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Research on Pfizer Inc. and Bristol-Myers Squibb Co. - Major Drug Manufacturers Look to Grow Revenues in Wake of Patent Expiries"
steht unter der journalistisch-redaktionellen Verantwortung von
StockCall (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
